ChristinaYu-YeeChanMD

PubMed

• 10 citations
  Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinica...
  Mark J. DiNubile, Ian R. Friedland, Christina Y. Chan, Mary Motyl, Hilde Giezek, Kathleen McCarroll, Malathi Shivaprakash, John P. Quinn, Robert A. Weinstein, Joseph W...> ;Diagnostic Microbiology and Infectious Disease. 2007 Aug 1
• 233 citations
  Decline in Varicella-Zoster Virus (VZV)–Specific Cell-Mediated Immunity with Increasing Age and Boosting with a High-Dose VZV Vaccine
  Myron J. Levin, Jeffrey G. Smith, Robin M. Kaufhold, Debra Barber, Anthony R. Hayward, Christina Y. Chan, Ivan S. F. Chan, David J. J. Li, William Wang, Paul M. Keller...> ;The Journal of Infectious Diseases. 2003 Nov 1
• 91 citations
  Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.
  Shu Li, Ivan S. F. Chan, Holly Matthews, Joseph F. Heyse, Christina Y. Chan, Barbara J. Kuter, Karen M. Kaplan, S. J. Vessey, Jerald C. Sadoff> ;The Pediatric Infectious Disease Journal. 2002 Apr 1

Journal Articles

• Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinica...  
  DiNubile M, Friedland IR, Chan CY, Motyl MR, Giezek H, McCarroll K, Shivaprakasha M, Quinn JP, Weinstein RA, Chow JW, Diagnostic Microbiology and Infectious Disease, 1/1/2007
• Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment  
  Schmoll HJ, Aapro MS, Poli-Bigelli S, Kim HK, Park K, Jordan K, von Pawel J, Giezek H, Ahmed T, Chan CY, Ann Oncol, 1/1/2006
• Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention  
  De La Pena AS, Asperger W, Kockerling F, Raz, P, Kafka R, Warren B, Shivaprakash M, Vrijens F, Giezek H, DiNubile M, Chan CY for the Optimimzing Intra-Abdominal surger..., J Gastrointest Surg, 1/1/2006
•  
  Diaz C, Dentico, P, Gonzalez R, Mendez RG, Cinquetti S, Barben JL, Harmon A, Chalikonda I, Smith JG, Stek JE, Robertson A, Caulfield MJ, Biasio LR, Silber JL, Chan CY,..., Vaccine, 1/1/2006
• Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections  
  Navarro N, Campos M, Alvarado R, Qunitero N, Branicki F, Wei J, Shivaprakash M, Vrijens F, Giezek H, Chan CY, and DiNubile MJ for the OASIS II Study Team, Int J Surgery, 1/1/2005
• Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: Observations from two randomized comparative clinica...  
  DiNubile M, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Weinstein RA, and Quinn JP, Eur J Clin Microbiol Infect Dis, 1/1/2005
• Varicella-Zoster Vaccine to prevent herpes zoster and postherpetic neuralgia in older adults  
  Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzz..., New Engl J Med, 1/1/2005
• Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: Safety, tolerability, ...  
  Hesley TM, Reisinger KS, Sullivan BJ, Jensen EH, Stasiorowski S, Meechan C, Chan CY, and West DJ, Pediatr Infect Dis J, 1/1/2004
• Microbiological results from a randomized, open-label study of ertapenem vs ceftriaxone/metronidazole for the treatment of community-acquired intraabdominal infections...  
  Campos M, Navarro N, Alvarado R, Quintero N, Branicki F, Wei J, Vrijens F, Giezek H, Shivaprakash M and Chan C, Int J Infect Dis, 1/1/2004
• Varicella vaccination in children with chronic renal failure: A report of the Southwest Pediatric Nephrology Study Group  
  Furth SL, Hogg RJ, Tarver J, Moulton LH, Chan C, and Fivush BA, Pediatr Nephrology, 1/1/2003
• Varicella vaccination in children with nephrotic syndrome: A report of the Southwest Pediatric Nephrology Study Group  
  Furth SL, Arbus G, Hogg R, Tarver J, Chan C, and Fivush BA, J Pediatr, 1/1/2003
• Measurement of cell-mediated immunity with a varicella-zoster virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster  
  Smith JG, Levin M, Vessey R, Chan ISF, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, Bernard M, Wang WW, Keller P, and Caulfield MJ, J Med Virol, 1/1/2003
• Decline in varicella-zoster (VZV)-specific cell mediated immunity with age and boosting with a high dose VZV vaccine  
  Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan ISF, Li DJJ, Wang W, Keller PM, Shaw A, Silber JL, Schlinger K, Chalikonda I, Vessey SJR, and Caul..., J of Infect Dis, 1/1/2003
• Inverse relationships between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection  
  Li S, Chan ISF, Matthews H, Heyse JF, Chan CY, Kuter BJ, Kaplan KM, Vessey SJR, and Sadoff JC, Pediatr Infect Dis J, 1/1/2002
• A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX� in healthy children  
  Lau YL, Vessey SJR, Chan ISF, Lee TL, Huang LM, Lee CY, Lin TY, Lee BW, Kwan K, Kasim SM, Chan CY, Kaplan KM, Distefano DJ, Harmon AL, Golie A, Hartzel J, Xu J, Li S, ..., Vaccine, 1/1/2002
• Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection aga...  
  Shinefield HR, Black SB, Staehle BO, Matthews H, Adelman T, Ensor K, Li S, Chan I, Heyse J, Waters M, Chan CY, Vessey SJR, Kaplan KM, Kuter BJ and The Kaiser Permanent..., Pediatr Infect Dis J, 1/1/2002
• Use of statistical models for evaluating antibody response as a correlate of protection against varicella  
  Chan ISF, Li S, Matthews H, Chan C, Vessey R, Sadoff J, and Heyse J, Statist. Med., 1/1/2002
• Childhood vaccination against varicella: Persistence of antibody, duration of protection, and vaccine efficacy  
  Vessey SJR, Chan CY, Kuter BJ, Kaplan KM, Waters M, Kutzler DP, Carfagno PA, Sadoff JC, Heyse JF, Matthews H, Li S, and Chan ISF, J Pediatr, 1/1/2001
• Immunization of HIV-infected children with varicella vaccine  
  Levin MJ, Gershon AA, Weinberg A, Blanchard S, Nowak B, Palumbo P, Chan CY, and the AIDS Clinical Trials Group 265 Team, J Pediatr, 1/1/2001
• Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older  
  Levin MJ, Ellison MC, Zerbe GO, Barber D, Chan C, Stinson D, Jones M and Hayward AR, Vaccine, 1/1/2000
• Postexposure effectiveness of varicella vaccine  
  Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, and Levenson R, Pediatrics, 1/1/2000
• Cytokine production in VZV-stimulated cultures of human blood lymphocytes  
  Hayward AR, Cosyns M, Jones M, Levin MJ, Villanueba E, Weinberg A, and Chan CY, J Infect Dis, 1/1/1998
• Cellular immunity to varicella-zoster virus in patients with major depression  
  Irwin M, Costlow C, Williams H, Artin KH, Levin MJ, Hayward AR, Chan CY, Stinson DL, and Oxman MN, J Infect Dis, 1/1/1998
• Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect  
  Levin MJ, Barber D, Goldblatt E, Jones M, Lafleur B, Chan C, Stinson D, Zerbe GO, and Hayward AR, J Infect Dis, 1/1/1998
• Antibody responses to Tetanus Toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT)  
  Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, Phillips NR, Schnipper C, and Ambrosino DM, Bone Marrow Transplantation, 1/1/1997
• Join now to see all

Abstracts/Posters

• Immunogenicity and safety of varicella-zoster virus (VZV) vaccine administered to older adults with or without diabetes mellitus (DM) or chronic obstructive pulmonary ...
  Schmader K, Bobrove A, Levin M, Oxman M, Tucker R, Reisinger K, Nunez M, Rothbaum J, Johnson P, Stek J, Thompson M, Rafalowski M, Klopfer S, Chan C, Sadoff J, Chan I a..., J Am Geriatr Soc, American Geriatrics Society 2006 Annual Scientific Meeting, Chicago, IL, 1/1/2006
• Comparison of aprepitant combination regimen with 3-day ondansetron + 4-day dexamethasone for prevention of acute and delayed nausea/vomiting after cisplatin chemother...
  Aapro MS, Schmoll HJ, Poli-Bigelli SP, Jordan K, von Pawel J, Giezek H, Ahmed T, and Chan CY, Annual Meeting of American Society of Clinical Oncology, Orlando, FL, 1/13/2005
• Dose-ranging safety and immunogenicity study of live-attenuated varicella-zoster virus vaccine (Oka/Merck) administered to adults 60 years of age or older.
  Levin MJ, Bobrove AM, Hayden FG, Hayward AR, Irwin M, Keller PM, Cheney CA, Sterling TM, Chan ISF, Yan X, Robertson AD, Chan CY, Silber JL, 99th Annual Scientific Assembly of the Southern Medical Association, San Antonio, TX, 1/10/2005
• Efficacy of ertapenem once a day for the treatment of intra-abdominal infections requiring surgical intervention: results of two prospective, randomised, open-label st...
  De La Pena A, Navarro N, Campos M, Asperger W, Shivaprakash M, Vrijens F, Giezek H, and Chan C, 17th Annual Meeting of Surgical Infection Society-Europe, Cork, Ireland, 1/18/2004
• Efficacy of ertapenem in the initial treatment of gram-negative pneumonia caused by enterobacteriaceae.
  Chan C, Friedland I, McCarroll K, Woods G, and DiNubile M, Third Forum on Respiratory Tract Infections, Monte Carlo, Morocco, 1/5/2004
• Treatment of pneumonia in the elderly with parenteral to oral antibiotic regimens: An analysis of clinical trials initiating therapy with ertapenem versus ceftriaxone ...
  Chan C, Friedland I, McCarroll K, Woods G, and DiNubile M, Third Forum on Respiratory Tract Infections, Monte Carlo, Morocco, 1/5/2004
• In vitro activity of ertapenem against macrolide- or levofloxacin-resistant Streptococcus pneumoniae.
  Motyl M, Dorso K, Chan C, Friedland I, and DiNubile M, Third Forum on Respiratory Tract Infections, Monte Carlo, Morocco, 1/5/2004
• Microbiological results from a randomized, open-label study of ertapenem vs. ceftriaxone/metronidazole for the treatment of community-acquired intra-abdominal infectio...
  Navarro N, Alvarado R, Quintero N, Branicki F, Wei J, Vrijens H, Giezek H, Shivaprakash M, and Chan C, 11th International Congress on Infectious Diseases, Cancun, Mexico, 1/4/2004
• Comparison of level of physician satisfaction with ertapenem, piperacillin/tazobactam and ceftriaxone/metronidazole for the treatment of community-acquired intra-abdom...
  De La Pena A, Navarro N, Asperger W, Mavros P., Chan C, Shivaprakash M, and Sen S, 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 1/1/2004
• Abscesses of skin and skin structures: insights from a randomised study of ertapenem vs. piperacillin-tazobactam.
  Gesser R, McCarroll K, Chan C, and DiNubile M, 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 1/1/2004
• Microbiological results from a randomized open-label study of ertapenem vs. piperacillin/tazobactam for the treatment of community-acquired intra-abdominal infections ...
  De La Pena A, Asperger W, Warren B, Kafka R, Raz R, Shivaprakash M, Vrijens F, Giezek H, Chan C, and Stek M, 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 1/1/2004
• Ertapenem vs. piperacillin/tazobactam for the treatment of intra-abdominal infections requiring surgical intervention (OASIS-1): results pf a prospective, randomized, ...
  De La Pena A, Asperger W, Kockerling F, Raz R, Kafka Rm Warren B, Shivaprakash M, Vrijens F, Giezek H, and Chan C, 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 1/1/2004
• Decline in varicella-zoster virus (VZV)-specific cell mediated immunity with age and boosting with a VZV vaccine.
  Caulfield MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan ISF, Li DJJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJR, and..., Gordon Research Conference on Viruses and Cells Meeting, Barga, Italy, 1/18/2003
• Ertapenem versus ceftriaxone/metronidazole for the treatment of intra-abdominal infections (IAI) requiring surgical intervention (OASIS-2): Results of a prospective, r...
  Navarro N, Campos M, Alvardo R, Qunitero-Perez N, Branicki F, Wei, JM, Vrijens F, Giezek H, Shivaprakash M, and Chan CY, Antimicrobial Chemotherapy in Clinical Practice 3rd International Meeting (ACCP), Santa Margherita, Portofino, Italy, 1/16/2003
• Emergence of resistant gram-negative bacilli in the bowel of patients treated with ceftriaxone/metronidazole vs. ertapenem for intraabdominal infections.
  Friedland I, Shivaprakash M, Giezek H, Motyl M, DiNubile M, and Chan C, Antimicrobial Chemotherapy in Clinical Practice 3rd International Meeting (ACCP), Santa Margherita, Portofino, Italy, 1/16/2003
• Decline in varicella-zoster virus (VZV)-specific cell mediated immunity with age and boosting with a VZV vaccine.
  Caulfield MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan ISF, Li DJJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJR, and..., Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 43rd Meeting, Chicago, IL, 1/14/2003
• Isolation of resistant faecal enterics in patients treated with piperacillin-tazobactam vs ertapenem.
  Friedland I, Chan C, Giezek H, Motyl M, Woods, G, and Shivaprakash M, European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) Meeting, Glasgow, United Kingdom, 1/10/2003
• Varivax� long-term efficacy and antibody (ab) persistence is similar in children vaccinated at age 12 to 14 months and at older ages.
  Silber JL, Matthews H, Kim LL, Chan CY, Kuter BJ, and Chan ISF, Infectious Disease Society of America Meeting (IDSA), San Diego, CA, 1/9/2003
• Varivax� (Varicella virus vaccine live (Oka/Merck)) in children in Taiwan.
  Huang LM, Lee CY, Poerschke G, and Chan CY, 10th International Congress on Infectious Diseases, Singapore, 1/11/2002
• Immunogenicity and persistence of antibody levels following VARIVAX� in children and adolescents with nephrotic syndrome: a report of the Southwest Pediatric Nephrolog...
  Fivush BA, Arbus G, Chan C, Green, K, Tarver J, Hogg R, and Furth SL, 31st Annual Meeting of American Society of Nephrology, Miami, 1/5/1999
• Safety, tolerability & immunogenicity of VARIVAX® in nephrotic syndrome: A report of the Southwestern Pediatric Nephrology Study Group.
  Furth S.L., Arbus G., Chan C., Green K., Tarver J., Hogg R., and Fivush B.A., Pediatr Res, 1/1/1999
• Safety, tolerability, and immunogenicity of VARIVAX� in children with chronic renal insufficiency (CRI). A preliminary report from the Southwest Pediatric Nephrology S...
  Furth S.L., Fivush B.A., Chan C., Green K., Tarver J., and Hogg R, Pediatric Nephrology International Meeting, London, United Kingdom, 1/12/1998
• Effectiveness and antibody persistence after VARIVAX� (varicella vaccine virus live (Oka/Merck)) in healthy children: An interim 5-year report of the long-term (10-yea...
  Chan CY, Li S, Bird S, Matthews H, Carfagno P, Kutzler D, Stinson D, Meechan C, Kuter B, Sadoff J, and VARIVAX� Study Group, 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1/1/1998
• VZV-specific immune responses six years after immunization of elderly individuals with a live attenuated varicella vaccine.
  Levin M, LaFleur B, Zerbe G, Barber D, Goldblatt E, Chan C, and Hayward A, Program and Abstracts of the Third International Conference on the Varicella-Zoster Virus, Palm Beach, 1/11/1997
• Cytokine production and estimates of responder cell frequency in VZV-stimulated cultures of human blood lymphocytes.
  Hayward AR, Jones M, Cosyns M, Chan C, and Levin M, Program and Abstracts of the Third International Conference on the Varicella-Zoster Virus, Palm Beach, 1/11/1997
• Join now to see all

Lectures

• "Industry commitment in the global elimination of cervical cancer." 
  Chicago, IL - 1/1/2006
• "Ethical consideration in developing new antimicrobial therapy." 
  Basel, Switzerland - 1/1/2005
• "Clinical Investigations" 
  San Francisco, CA - 1/1/1997
• "How do we know vaccines are safe?" 
  Detroit, MI - 1/1/1997
• "First Annual Report on the Long-term Antibody Persistence & Vaccine Effectiveness Follow-up Studies." 
  Rockville, MD - 1/1/1997
• "Safety and Efficacy of the Varicella Vaccine" 
  Lackland, TX - 1/1/1996
• Join now to see all